Advertisement
Screener

Associated Banc-Corp (ASB) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

2.3 / 5 stars · 52/113 Roast Me

Associated Banc-Corp Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

Associated Banc-Corp (ASB) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $33.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-05.

Discontinued › Income Statement › Other Income

us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2012-11-05

  • Associated Banc-Corp derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
  • Associated Banc-Corp derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2012-06-30 was $15.00K, a 16.67% decline year-over-year.
  • Associated Banc-Corp derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2012-03-31 was $18.00K.
  • Associated Banc-Corp derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2011-09-30 was $24.00K.
Period endDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
$15.00K
derived: sum of 2 quarters · filed 2012-11-05
$33.00K
10-Q · filed 2012-11-05
2012-06-30$15.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
$33.00K
10-Q · filed 2012-08-03
2012-03-31$18.00K
10-Q · filed 2012-05-07
2011-09-30$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
$42.00K
derived: sum of 2 quarters · filed 2012-11-05
$18.00K
10-Q · filed 2012-11-05
2011-06-30$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
-$6.00K
10-Q · filed 2012-08-03
2011-03-31-$24.00K
10-Q · filed 2012-05-07
2010-09-30-$1.00K
10-Q · filed 2011-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ameris Bancorp (ABCB)United States$5.490B16.15
Atlantic Union Bankshares Corp (AUB)United States$5.502B12.34
GLACIER BANCORP, INC. (GBCI)United States$5.776B21.55
HOME BANCSHARES INC (HOMB)United States$5.794B
HANCOCK WHITNEY CORP (HWC)United States$5.871B14.07
UNITED BANKSHARES INC/WV (UBSI)United States$6.340B12.26
FIRST FINANCIAL BANKSHARES INC (FFIN)United States$4.610B18.43
INTERNATIONAL BANCSHARES CORP (IBOC)United States$4.312B11.43
TEXAS CAPITAL BANCSHARES INC/TX (TCBI)United States$4.116B12.37
FIRST BANCORP /PR/ (FBP)$4.092B10.69